ORL1

AcronymDefinition
ORL1Opioid Receptor-Llike 1
References in periodicals archive ?
The report provides comprehensive information on the Nociceptin Receptor (Kappa-Type 3 Opioid Receptor or KOR-3 or Orphanin FQ Receptor or OPRL1 or OOR or ORL1), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.
* The report provides a snapshot of the global therapeutic landscape for Nociceptin Receptor (Kappa-Type 3 Opioid Receptor or KOR-3 or Orphanin FQ Receptor or OPRL1 or OOR or ORL1)
Agonist-independent modulation of N-type calcium channels by ORL1 receptors.
A OANC [H.sub.2]O 4.50% ORL0 B 3.70% ORL0 C 3.50% ORL1 D LRNC VOC 7.00% ROL1 E 7.00% ROL1 F 4.25% ROM0 G 6.00% ROL0 H 2.90% ORL0 I OAWS VOC 19.50% ORH1 J [H.sub.2]O 7.00% ORH1 K 20.0% ORH1 L 22.4% ORH1 M 19.5% ORH1 N HRNC VOC 15.0% ROM1 O 15.0% ORL1 P LVRE >50% [H.sub.2]O 6.20% ORL0 Q >50% VOC 2.40% ROL0 Table 4.
Traynor, "Comparison of the in vitro efficacy of p, S, k and ORL1 receptor agonists and nonselective opioid agonists in dog brain membranes," Brain Research, vol.